Accurate measurement of allergic skin reactions is a longstanding challenge in allergy diagnostics. In skin prick tests, small amounts of allergens are introduced into the skin to trigger minor, localized reactions, which are then measured to determine the patient’s sensitivity. However, this process typically relies on manual, visual assessments, which are susceptible to variability. Differences in lighting, skin tone, and even the experience of the healthcare provider can influence the measurement, leading to inconsistent results that impact diagnostic accuracy. For patients, this means the possibility of incorrect diagnoses, unnecessary follow-up tests, or ineffective treatment plans.
To address this, the Clínica Universidad de Navarra (CUN) developed the Nexkin DSPT, a 3D laser device designed to provide a precise, objective assessment of skin reactions in intradermal allergy testing. Recently highlighted in Clinical and Experimental Allergy, this innovative tool uses high-definition laser imaging to measure allergic responses with a level of accuracy beyond manual methods.
The Nexkin DSPT works by capturing a 3D image of the allergic reaction, enabling a standardized and reproducible measurement that minimizes human error. By eliminating the subjectivity of manual assessment, the device allows for a more consistent evaluation, which could lead to faster, more reliable diagnoses. For patients, this means a reduction in the need for repeated tests and more effective, personalized treatment options.
The device’s development comes as allergies are on the rise globally, with precision in testing becoming increasingly important. Early studies conducted at CUN have shown that the Nexkin DSPT aligns closely with both clinical observations and patient-reported symptoms, making it a valuable tool in bridging the gap between patient experiences and objective diagnostic data.
Article written by InfoSalus
16/10/2024
Source:
Info Salus
https://www.euskalit.net/buscador/uploads/25-1_Hospital_Santa_Marina.pdf